no more compounding glp 1 drugs GLP-1 from the Gray Market Patients struggle as compounded GLP-1
Description
Find out if a GLP-1 agonist is right for you It can be overwhelming to start a weight-loss program
Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcelo-Coblijn GC, Nussbaum RL
GLP-1 innovation vector (3): Manufacturing and supply chain After more than a year of severe shortages, both semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have recently come off the FDAs shortage listan encouraging signal that supply is stabilizing
Med J Aust 2024;220:1416
Click to enlarge the figure
DA: Writing original draft, Formal analysis
